United States Low T Therapy Market Report 2017

Table of Contents

United States Low T Therapy Market Report 2017
1 Low T Therapy Overview
1.1 Product Overview and Scope of Low T Therapy
1.2 Classification of Low T Therapy by Product Category
1.2.1 United States Low T Therapy Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Low T Therapy Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Gels
1.2.4 Injections
1.2.5 Patches
1.2.6 Other
1.3 United States Low T Therapy Market by Application/End Users
1.3.1 United States Low T Therapy Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 United States Low T Therapy Market by Region
1.4.1 United States Low T Therapy Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Low T Therapy Status and Prospect (2012-2022)
1.4.3 Southwest Low T Therapy Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Low T Therapy Status and Prospect (2012-2022)
1.4.5 New England Low T Therapy Status and Prospect (2012-2022)
1.4.6 The South Low T Therapy Status and Prospect (2012-2022)
1.4.7 The Midwest Low T Therapy Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Low T Therapy (2012-2022)
1.5.1 United States Low T Therapy Sales and Growth Rate (2012-2022)
1.5.2 United States Low T Therapy Revenue and Growth Rate (2012-2022)

2 United States Low T Therapy Market Competition by Players/Suppliers
2.1 United States Low T Therapy Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Low T Therapy Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Low T Therapy Average Price by Players/Suppliers (2012-2017)
2.4 United States Low T Therapy Market Competitive Situation and Trends
2.4.1 United States Low T Therapy Market Concentration Rate
2.4.2 United States Low T Therapy Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Low T Therapy Manufacturing Base Distribution, Sales Area, Product Type

3 United States Low T Therapy Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Low T Therapy Sales and Market Share by Region (2012-2017)
3.2 United States Low T Therapy Revenue and Market Share by Region (2012-2017)
3.3 United States Low T Therapy Price by Region (2012-2017)

4 United States Low T Therapy Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Low T Therapy Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Low T Therapy Revenue and Market Share by Type (2012-2017)
4.3 United States Low T Therapy Price by Type (2012-2017)
4.4 United States Low T Therapy Sales Growth Rate by Type (2012-2017)

5 United States Low T Therapy Sales (Volume) by Application (2012-2017)
5.1 United States Low T Therapy Sales and Market Share by Application (2012-2017)
5.2 United States Low T Therapy Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Low T Therapy Players/Suppliers Profiles and Sales Data
6.1 AbbVie
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Low T Therapy Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 AbbVie Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Endo International
6.2.2 Low T Therapy Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Endo International Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Eli Lilly
6.3.2 Low T Therapy Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Eli Lilly Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.2 Low T Therapy Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Actavis (Allergan)
6.5.2 Low T Therapy Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Actavis (Allergan) Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Bayer
6.6.2 Low T Therapy Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Bayer Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novartis
6.7.2 Low T Therapy Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novartis Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Teva
6.8.2 Low T Therapy Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Teva Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Mylan
6.9.2 Low T Therapy Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Mylan Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Upsher-Smith
6.10.2 Low T Therapy Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Upsher-Smith Low T Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Ferring Pharmaceuticals
6.12 Kyowa Kirin
6.13 Acerus Pharmaceuticals

7 Low T Therapy Manufacturing Cost Analysis
7.1 Low T Therapy Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Low T Therapy

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Low T Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Low T Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Low T Therapy Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Low T Therapy Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Low T Therapy Sales Volume Forecast by Type (2017-2022)
11.3 United States Low T Therapy Sales Volume Forecast by Application (2017-2022)
11.4 United States Low T Therapy Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Low T Therapy
Figure United States Low T Therapy Market Size (K Pcs) by Type (2012-2022)
Figure United States Low T Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Gels Product Picture
Figure Injections Product Picture
Figure Patches Product Picture
Figure Other Product Picture
Figure United States Low T Therapy Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Low T Therapy by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Low T Therapy Market Size (Million USD) by Region (2012-2022)
Figure The West Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low T Therapy Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Low T Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Low T Therapy Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Low T Therapy Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Low T Therapy Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low T Therapy Sales Share by Players/Suppliers
Figure 2017 United States Low T Therapy Sales Share by Players/Suppliers
Figure United States Low T Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Low T Therapy Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Low T Therapy Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Low T Therapy Revenue Share by Players/Suppliers
Figure 2017 United States Low T Therapy Revenue Share by Players/Suppliers
Table United States Market Low T Therapy Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Low T Therapy Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Low T Therapy Market Share of Top 3 Players/Suppliers
Figure United States Low T Therapy Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Low T Therapy Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Low T Therapy Product Category
Table United States Low T Therapy Sales (K Pcs) by Region (2012-2017)
Table United States Low T Therapy Sales Share by Region (2012-2017)
Figure United States Low T Therapy Sales Share by Region (2012-2017)
Figure United States Low T Therapy Sales Market Share by Region in 2016
Table United States Low T Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Low T Therapy Revenue Share by Region (2012-2017)
Figure United States Low T Therapy Revenue Market Share by Region (2012-2017)
Figure United States Low T Therapy Revenue Market Share by Region in 2016
Table United States Low T Therapy Price (USD/Pcs) by Region (2012-2017)
Table United States Low T Therapy Sales (K Pcs) by Type (2012-2017)
Table United States Low T Therapy Sales Share by Type (2012-2017)
Figure United States Low T Therapy Sales Share by Type (2012-2017)
Figure United States Low T Therapy Sales Market Share by Type in 2016
Table United States Low T Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Low T Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Low T Therapy by Type (2012-2017)
Figure Revenue Market Share of Low T Therapy by Type in 2016
Table United States Low T Therapy Price (USD/Pcs) by Types (2012-2017)
Figure United States Low T Therapy Sales Growth Rate by Type (2012-2017)
Table United States Low T Therapy Sales (K Pcs) by Application (2012-2017)
Table United States Low T Therapy Sales Market Share by Application (2012-2017)
Figure United States Low T Therapy Sales Market Share by Application (2012-2017)
Figure United States Low T Therapy Sales Market Share by Application in 2016
Table United States Low T Therapy Sales Growth Rate by Application (2012-2017)
Figure United States Low T Therapy Sales Growth Rate by Application (2012-2017)
Table AbbVie Basic Information List
Table AbbVie Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Low T Therapy Sales Growth Rate (2012-2017)
Figure AbbVie Low T Therapy Sales Market Share in United States (2012-2017)
Figure AbbVie Low T Therapy Revenue Market Share in United States (2012-2017)
Table Endo International Basic Information List
Table Endo International Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Endo International Low T Therapy Sales Growth Rate (2012-2017)
Figure Endo International Low T Therapy Sales Market Share in United States (2012-2017)
Figure Endo International Low T Therapy Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Eli Lilly Low T Therapy Sales Growth Rate (2012-2017)
Figure Eli Lilly Low T Therapy Sales Market Share in United States (2012-2017)
Figure Eli Lilly Low T Therapy Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Low T Therapy Sales Growth Rate (2012-2017)
Figure Pfizer Low T Therapy Sales Market Share in United States (2012-2017)
Figure Pfizer Low T Therapy Revenue Market Share in United States (2012-2017)
Table Actavis (Allergan) Basic Information List
Table Actavis (Allergan) Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Actavis (Allergan) Low T Therapy Sales Growth Rate (2012-2017)
Figure Actavis (Allergan) Low T Therapy Sales Market Share in United States (2012-2017)
Figure Actavis (Allergan) Low T Therapy Revenue Market Share in United States (2012-2017)
Table Bayer Basic Information List
Table Bayer Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Low T Therapy Sales Growth Rate (2012-2017)
Figure Bayer Low T Therapy Sales Market Share in United States (2012-2017)
Figure Bayer Low T Therapy Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis Low T Therapy Sales Growth Rate (2012-2017)
Figure Novartis Low T Therapy Sales Market Share in United States (2012-2017)
Figure Novartis Low T Therapy Revenue Market Share in United States (2012-2017)
Table Teva Basic Information List
Table Teva Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Low T Therapy Sales Growth Rate (2012-2017)
Figure Teva Low T Therapy Sales Market Share in United States (2012-2017)
Figure Teva Low T Therapy Revenue Market Share in United States (2012-2017)
Table Mylan Basic Information List
Table Mylan Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Mylan Low T Therapy Sales Growth Rate (2012-2017)
Figure Mylan Low T Therapy Sales Market Share in United States (2012-2017)
Figure Mylan Low T Therapy Revenue Market Share in United States (2012-2017)
Table Upsher-Smith Basic Information List
Table Upsher-Smith Low T Therapy Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Upsher-Smith Low T Therapy Sales Growth Rate (2012-2017)
Figure Upsher-Smith Low T Therapy Sales Market Share in United States (2012-2017)
Figure Upsher-Smith Low T Therapy Revenue Market Share in United States (2012-2017)
Table Ferring Pharmaceuticals Basic Information List
Table Kyowa Kirin Basic Information List
Table Acerus Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Low T Therapy
Figure Manufacturing Process Analysis of Low T Therapy
Figure Low T Therapy Industrial Chain Analysis
Table Raw Materials Sources of Low T Therapy Major Players/Suppliers in 2016
Table Major Buyers of Low T Therapy
Table Distributors/Traders List
Figure United States Low T Therapy Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Low T Therapy Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Low T Therapy Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Low T Therapy Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Low T Therapy Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Low T Therapy Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Low T Therapy Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Low T Therapy Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Low T Therapy Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Low T Therapy Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Low T Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low T Therapy Sales Volume Share Forecast by Region (2017-2022)
Figure United States Low T Therapy Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.